Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Ghrelin in Frail Elderly Subcutaneous Repeated Dose Study

Authors not listed

University of Pennsylvania · 2013

Abstract

Frailty is a geriatric syndrome leading to physical deterioration including muscle wasting (sarcopenia) and unintentional weight loss. There are currently no approved therapies for frailty. Ghrelin is a hormone produced by the stomach that stimulates appetite centers in the brain. The investigators already know that a single dose of Ghrelin improves food intake immediately after the dose in frail older people. In this study, the investigators are trying to find out if repeated daily doses of ghrelin will help frail older people improve food intake for multiple days in a row.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-31 MST

Cite this

APA
Anonymous. (2013). Ghrelin in Frail Elderly Subcutaneous Repeated Dose Study. <em>University of Pennsylvania</em>. https://clinicaltrials.gov/study/NCT01833078
Vancouver
Anonymous. Ghrelin in Frail Elderly Subcutaneous Repeated Dose Study. University of Pennsylvania. 2013.
BibTeX
@misc{anon2013Ghreli, title = {Ghrelin in Frail Elderly Subcutaneous Repeated Dose Study}, author = {Anonymous}, journal = {University of Pennsylvania}, year = {2013}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings